Skip to main content
Premium Trial:

Request an Annual Quote

23andMe Pledges QC

23andMe took to its blog, The Spittoon, yesterday to provide a public update on the recent sample switch-up at its contracted partner, LabCorp. The DTC firm confirms that "the processing mistake was caused by human error and the incorrect placement of a single 96-well plate used in processing samples." 23andMe writes that, along with their contracted laboratory, they are taking measures to prevent future mix-ups. Namely, LabCorp "has adjusted the mounting process for these 96-well plates and this new adjustment physically prevents any incorrect manual placement of the plates used at this step of processing," and 23andMe will collect basic survey data from its customers — regarding sex, at the least — as "an additional quality check [that] can be conducted prior to uploading data."

Daniel MacArthur at Genetic Future, who broke the news from a password-protected 23andMe statement this week, applauds the DTC firm "for responding to this problem, rapidly implementing a solution, and discussing the situation openly," but says that perhaps the company and its lab should consider adopting "more elaborate plate-tracking measures — such as the incorporation of known control samples at different positions in each plate being processed, serving as a kind of molecular barcode."

23andMe says that they've now uploaded the correct data to customers who were impacted by the error.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.